Clinical Trials for Drug: Obinutuzumab (GA101)

1 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-16-65 A Phase 1 clinical trial to evaluate obinutuzumab with high-dose ibrutinib for the treatment of patients with chronic lymphocytic leukemia with progressive disease on single agent ibrutinib Open